Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Experimental Cell Research
|
December 7, 2005
VEGF function in vascular pathogenesis
Yin-Shan Ng, Dominik Krilleke, David T Shima
Biochemical Society Transactions
|
November 14, 2009
The heparin-binding domain confers diverse functions of VEGF-A in development and disease: a structure-function study
Dominik Krilleke, Yin-Shan Eric Ng, David T Shima
International Journal of Cancer
|
October 2, 2003
Inhibition of JNK signaling diminishes early but not late cellular stress-induced apoptosis
Dominik Krilleke, Esat Ucur, Dianne Pulte, et al.
The Journal of Biological Chemistry
|
July 13, 2007
Molecular mapping and functional characterization of the VEGF164 heparin-binding domain
Dominik Krilleke, Andrea DeErkenez, William Schubert, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 17, 2005
A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165
Joon-Hwa Lee, Marella D Canny, Andrea De Erkenez, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Experimental Cell Research
|
December 7, 2005
VEGF function in vascular pathogenesis
Yin-Shan Ng, Dominik Krilleke, David T Shima
Biochemical Society Transactions
|
November 14, 2009
The heparin-binding domain confers diverse functions of VEGF-A in development and disease: a structure-function study
Dominik Krilleke, Yin-Shan Eric Ng, David T Shima
International Journal of Cancer
|
October 2, 2003
Inhibition of JNK signaling diminishes early but not late cellular stress-induced apoptosis
Dominik Krilleke, Esat Ucur, Dianne Pulte, et al.
The Journal of Biological Chemistry
|
July 13, 2007
Molecular mapping and functional characterization of the VEGF164 heparin-binding domain
Dominik Krilleke, Andrea DeErkenez, William Schubert, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 17, 2005
A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165
Joon-Hwa Lee, Marella D Canny, Andrea De Erkenez, et al.
Page
of 1